Zhitong Finance App News, Microchip Biotech (688321.SH) issued an announcement. The company recently received the “Notice of Acceptance” issued by the Drug Evaluation Center of the State Drug Administration for registered clinical trials of domestically produced drugs. The clinical trial application for injectable NW001 developed by the company in cooperation with Chengdu Microchip Xinyu Biotechnology Co., Ltd. to treat advanced malignant tumors (solid tumors and lymphoma) was accepted.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Microchip Biotech (688321.SH) issued an announcement. The company recently received the “Notice of Acceptance” issued by the Drug Evaluation Center of the State Drug Administration for registered clinical trials of domestically produced drugs. The clinical trial application for injectable NW001 developed by the company in cooperation with Chengdu Microchip Xinyu Biotechnology Co., Ltd. to treat advanced malignant tumors (solid tumors and lymphoma) was accepted.